Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 73.62 USD
Market Cap: 8.7B USD

HSIC's latest stock split occurred on Feb 8, 2019

The company executed a 1275-for-1000 stock split, meaning that for every 1000 shares held, investors received 1275 new shares.

Before the split, HSIC traded at 79.6493 per share. Afterward, the share price was about 59.15.

The adjusted shares began trading on Feb 8, 2019. This was HSIC's 3rd stock split, following the previous one in Sep 15, 2017.

Last Splits:
Feb 8, 2019
1275-for-1000
Sep 15, 2017
2-for-1
Mar 1, 2005
2-for-1
Pre-Split Price
62.47 79.6493
Post-Split Price
59.15
Before
After
Last Splits:
Feb 8, 2019
1275-for-1000
Sep 15, 2017
2-for-1
Mar 1, 2005
2-for-1

Henry Schein Inc
Stock Splits History

HSIC Stock Splits Timeline
Feb 8, 2019
Feb 8, 2019
Split 1275-for-1000
x1.275
Pre-Split Price
62.47 79.6493
Post-Split Price
59.15
Before
After
Sep 15, 2017
Sep 15, 2017
Split 2-for-1
x2
Pre-Split Price
63.1638 161.0676
Post-Split Price
64.9707
Before
After
Mar 1, 2005
Mar 1, 2005
Split 2-for-1
x2
Pre-Split Price
14.1771 72.303
Post-Split Price
14.7807
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
47.5 47.5 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
60.6 60.6 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HSIC Intrinsic Value
106.27 USD
Undervaluation 31%
Intrinsic Value
Price
Back to Top